Recent developments and primary care goals for ovarian cancer

For primary care teams, keeping up-to-date with developments and current best practice is the key to expediting ovarian cancer diagnosis, according to Dr Sharon Tate, Head of Primary Care Development, Target Ovarian Cancer (TOC). A national clinical audit and the approval of niraparib are two important, recent developments for ovarian cancer. Government funding for a national ovarian cancer audit (in […]

Diagnosis and self-help for ovarian cancer

It is a complete myth that ovarian cancer is a silent killer – even early-stage disease causes symptoms and knowing what they are is key to early treatment, according to Dr Sharon Tate, Head of Primary Care Development, Target Ovarian Cancer (TOC). Target Ovarian Cancer works hard to stamp out the myth of ‘the silent killer’, says Dr Tate. In […]

Ovarian cancer – facts and symptoms

Two thirds of UK women with ovarian cancer are diagnosed late when the cancer has spread and is difficult to treat.  IMI spoke to Dr Sharon Tate, Head of Primary Care Development, Target Ovarian Cancer (TOC) to find out more. More than 7000 women, mainly over the age of 50 years, are diagnosed with ovarian cancer every year in the […]